In 2023, global digital health funding halved for the second year in a row with just $13.2 billion raised in 1,397 deals, according to CB Insights. Deal size was around $4 million and the median digital health deal size trended upward. However, there were only three $100 million-plus deals in the fourth quarter of last year and the digital health unicorns are becoming even less common.
The digital health market has also seen consolidation and partnerships to further integrate into hospitals and health systems. Yahoo Finance compiled the 12 most valuable U.S.-based digital health companies based on current market caps.
1. CVS Health: $97 billion
2. DexCom: $44.5 billion
3. IQVIA: $42.7 billion
4. Veeva Systems: $34.6 billion
5. Simulations Plus: $8.2 billion
6. Doximity: $5.3 billion
7. Health Catalyst: $5.3 billion
8. NeuroPace: $4.1 billion
9. DocGo: $3.6 billion
10. Movano: $3.4 billion
11. Amwell: $3.3 billion
12. 23andMe: $3.2 billion
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
